Biblio

Author Title [ Type(Asc)] Year
Filters: Author is Kanate, Abraham S  [Clear All Filters]
Journal Article
Kanate AS, Majhail N, DeFilipp ZM, Dhakal B, Dholaria B, Hamilton B, Herrera AF, Inamoto Y, Jain T, Perales M-A, et al. Updated Indications for Immune Effector Cell Therapy: 2023 Guidelines from the American Society for Transplantation and Cellular Therapy. Transplant Cell Ther. 2023.
Scott EC, Hari P, Kumar S, Fraser R, Davila O, Shah N, Gale RPeter, Díaz MÁngel, Agrawal V, Cornell RF, et al. Staging Systems for Newly Diagnosed Myeloma Patients undergoing Autologous Hematopoietic Cell Transplant: The Revised International Staging System shows the most Differentiation between Groups. Biol Blood Marrow Transplant. 2018.
Gopalakrishnan S, D'Souza A, Scott E, Fraser R, Davila O, Shah N, Gale RPeter, Kamble R, Díaz MÁngel, Lazarus HM, et al. Revised-International Staging System (R-ISS) is Predictive and Prognostic for Early Relapse (<24 months) after Autologous Transplantation for Newly Diagnosed Multiple Myeloma (MM).. Biol Blood Marrow Transplant. 2018.
Austin K, Sweet M, Likar E, P LaSala R, Murray A, Wen S, Ross KG, Kanate AS, Veltri L, Matuga R, et al. Prospective assessment of Clostridioides (formerly Clostridium) difficile colonization and acquisition in hematopoietic stem cell transplant patients. Transpl Infect Dis. 2020:e13438.
Farris JC, Ritter A, Craig MD, Shah N, Veltri L, Kanate AS, Ross K, Vargo JA. Patterns of Relapse after Salvage Autologous Stem Cell Transplant for Hodgkin's Lymphoma: Should Sites of Relapse Relative to Initially Involved Sites Be Used to Guide Indications for Peri-transplant Radiotherapy. Pract Radiat Oncol. 2018.
Hanks CR, Slain D, Kanate AS, Wen S, Cumpston A. Impact of Anti-anaerobic Antibiotic Activity on Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients at an Institution that Utilizes Antibiotic Cycling. Transpl Infect Dis. 2021:e13676.
Mussetti A, Kanate AS, Wang T, He M, Hamadani M, Sr HFinel, Boumendil A, Glass B, Castagna L, Dominietto A, et al. Haploidentical versus matched unrelated donor transplants using post-transplant cyclophosphamide for lymphomas. Transplant Cell Ther. 2022.